Nimesulide
- Generic Name
- Nimesulide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C13H12N2O5S
- CAS Number
- 51803-78-2
- Unique Ingredient Identifier
- V4TKW1454M
- Background
Nimesulide is a relatively COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. Its approved indications are the treatment of acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea in adolescents and adults above 12 years old. Due to concerns about the risk of hepatotoxicity, nimesulide has been withdrawn from market in many countries.
- Indication
For the treatment of acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea in adolescents and adults above 12 years old.
- Associated Conditions
- Acute Pain, Menstrual Distress (Dysmenorrhea), Pain
- Associated Therapies
- NSAIDs
Comparative Analysis of the Effectiveness of the Use of Nimesulide and CBD Oil in Patients With Pain in the Preauricular Region Due to the Pain-dysfunctional Syndrome of the Temporomandibular Joint.
- Conditions
- Temporomandibular Joint DisordersTemporomandibular Joint Dysfunction SyndromeTemporomandibular Joint Pain
- Interventions
- First Posted Date
- 2020-10-30
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- Pomeranian Medical University Szczecin
- Target Recruit Count
- 30
- Registration Number
- NCT04609748
- Locations
- 🇵🇱
Chair and Depratment of Dental Prosthetics, Szczecin, Poland
Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis
- First Posted Date
- 2014-09-01
- Last Posted Date
- 2014-09-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 128
- Registration Number
- NCT02229747
A Prevention Trial in Subjects at High Risk for Breast Cancer
- First Posted Date
- 2011-12-28
- Last Posted Date
- 2014-06-18
- Lead Sponsor
- European Institute of Oncology
- Target Recruit Count
- 150
- Registration Number
- NCT01500577
- Locations
- 🇮🇹
European Institute of Oncology, Milan, Italy
Efficacy of Diclofenac Potassium vs Nimesulide in the Treatment of Fever and Pain in Children With Upper Respiratory Tract Infection
- Conditions
- Upper Respiratory Tract Infections
- Interventions
- First Posted Date
- 2010-12-09
- Last Posted Date
- 2012-04-26
- Lead Sponsor
- Novartis Pharmaceuticals
- Registration Number
- NCT01257126
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.